Neuralink Corp. is a US-based neurotechnology company focused on developing implantable brain-computer interfaces, founded by Elon Musk and a team of 7 scientists and engineers. Elon Musk on Monday announced that the company has successfully implanted one of its wireless brain chips in a human.

The company aims to connect human brains to computers and help tackle complex neurological conditions. However, several rival companies have already implanted similar devices.

The US FDA gave the product clearance and permission to conduct its first trial to test the implant on humans.

This gave the green light for the start of the six-year study during which a robot is being used to surgically place 64 flexible threads, thinner than a human hair, onto a part of the brain that controls “movement intention”, according to Neuralink.

“Initial results show promising neuron spike detection,” Musk added.

Neuronal activity is characterized by spikes, according to the National Institute of Health, with neurons being cells that utilize electrical and chemical signals to transmit information within the brain and the rest of the body.

The startup’s Prime study involves a trial for its wireless brain-computer interface, aiming to assess the safety of the implant and surgical robot. According to its website, the study is going to assess the functionality of the interface, enabling people with quadriplegia, or paralysis of all four limbs to control devices with their thoughts.

In reference to the late British scientist who battled motor neuron disease, Musk mentioned, “Imagine if Stephen Hawking could communicate faster than a speed typist or auctioneer. That is the goal.”

Despite Mr. Musk’s participation elevating the visibility of Neuralink, he encounters competition from rivals, some of whom have a history spanning two decades. Utah-based Blackrock Neurotech, for instance, implanted its initial brain-computer interface in 2004.